Literature DB >> 19238334

The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC).

Mojca Strazisar1, Vid Mlakar, Damjan Glavac.   

Abstract

Several studies have reported different expression levels of certain genes in NSCLC, mostly related to the stage and advancement of the tumours. We investigated 65 stage I-III NSCLC tumours: 32 adenocarcinomas (ADC), 26 squamous cell carcinomas (SCC) and 7 large cell carcinomas (LCC). Using the real-time reverse transcription polymerase chain reaction (RT-PCR), we analysed the expression of the COX-2, hTERT, MDM2, LATS2 and S100A2 genes and researched the relationships between the NSCLC types and the differences in expression levels. The differences in the expression levels of the LATS2, S100A2 and hTERT genes in different types of NSCLC are significant. hTERT and COX-2 were over-expressed and LATS2 under-expressed in all NSCLC. We also detected significant relative differences in the expression of LATS2 and MDM2, hTERT and MDM2 in different types of NSCLC. There was a significant difference in the average expression levels in S100A2 for ADC and SCC. Our study shows differences in the expression patterns within the NSCLC group, which may mimic the expression of the individual NSCLC type, and also new relationships in the expression levels for different NSCLC types.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238334      PMCID: PMC6275926          DOI: 10.2478/s11658-009-0011-7

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  54 in total

1.  Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.

Authors:  Zheng Jiang; Xingang Li; Jin Hu; Wei Zhou; Yuquan Jiang; Gang Li; Daru Lu
Journal:  Neurosci Res       Date:  2006-10-17       Impact factor: 3.304

2.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

3.  Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.

Authors:  Huijun Wang; Zhengdong Zhang; Ruiyun Li; K Kian Ang; Huazhong Zhang; Nancy P Caraway; Ruth L Katz; Feng Jiang
Journal:  Int J Cancer       Date:  2005-08-20       Impact factor: 7.396

4.  S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.

Authors:  Sven Diederichs; Etmar Bulk; Björn Steffen; Ping Ji; Lara Tickenbrock; Kerstin Lang; Kurt S Zänker; Ralf Metzger; Paul M Schneider; Volker Gerke; Michael Thomas; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

5.  Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.

Authors:  John Peter McPherson; Laura Tamblyn; Andrew Elia; Eva Migon; Amro Shehabeldin; Elzbieta Matysiak-Zablocki; Bénédicte Lemmers; Leonardo Salmena; Anne Hakem; Jason Fish; Farah Kassam; Jeremy Squire; Benoit G Bruneau; M Prakash Hande; Razqallah Hakem
Journal:  EMBO J       Date:  2004-09-02       Impact factor: 11.598

Review 6.  Lung cancer and cyclooxygenase-2.

Authors:  J Esteban Castelao; Robert D Bart; Costanzo A DiPerna; Eric M Sievers; Ross M Bremner
Journal:  Ann Thorac Surg       Date:  2003-10       Impact factor: 4.330

Review 7.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

8.  Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.

Authors:  Yuri Takahashi; Yasuo Miyoshi; Koji Morimoto; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-02-13       Impact factor: 4.322

9.  A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.

Authors:  G Nishimura; S Yanoma; H Mizuno; K Kawakami; M Tsukuda
Journal:  Jpn J Cancer Res       Date:  1999-10

10.  Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.

Authors:  Nur Duale; Birgitte Lindeman; Mitsuko Komada; Ann-Karin Olsen; Ashild Andreassen; Erik J Soderlund; Gunnar Brunborg
Journal:  Mol Cancer       Date:  2007-08-21       Impact factor: 27.401

View more
  14 in total

1.  TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-02-18

2.  Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.

Authors:  V Shane Pankratz; Zhifu Sun; Jeremiah Aakre; Yan Li; Cassandra Johnson; Yolanda I Garces; Marie C Aubry; Julian R Molina; Dennis A Wigle; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

3.  Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo.

Authors:  Ju-Feng Zhang; Fang Wei; Hui-Ping Wang; Hui-Ming Li; Wei Qiu; Peng-Kang Ren; Xia-Fang Chen; Qian Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-05-20

4.  Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.

Authors:  Susan Y Luo; Ko-Yung Sit; Alan D L Sihoe; Wai-Sing Suen; Wing-Kuk Au; Ximing Tang; Edmond S K Ma; Wai-Kong Chan; Ignacio I Wistuba; John D Minna; George S W Tsao; David C L Lam
Journal:  Lung Cancer       Date:  2014-06-16       Impact factor: 5.705

5.  Expression and significance of cyclooxygenase-2 mRNA in benign and malignant ascites.

Authors:  Jing Lu; Xiao-Feng Li; Li-Xia Kong; Lin Ma; Su-Huan Liao; Chang-You Jiang
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 6.  A Decade of GWAS Results in Lung Cancer.

Authors:  Yohan Bossé; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-14       Impact factor: 4.254

7.  Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.

Authors:  Maria N Timofeeva; Rayjean J Hung; Thorunn Rafnar; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; James D McKay; Yufei Wang; Juncheng Dai; Valerie Gaborieau; John McLaughlin; Darren Brenner; Steven A Narod; Neil E Caporaso; Demetrius Albanes; Michael Thun; Timothy Eisen; H-Erich Wichmann; Albert Rosenberger; Younghun Han; Wei Chen; Dakai Zhu; Margaret Spitz; Xifeng Wu; Mala Pande; Yang Zhao; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Maiken Elvestad Gabrielsen; Frank Skorpen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Simone Benhamou; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Thomas Muley; Hendrik Dienemann; Gudmar Thorleifsson; Hongbing Shen; Kari Stefansson; Paul Brennan; Christopher I Amos; Richard Houlston; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2012-08-16       Impact factor: 6.150

8.  Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk.

Authors:  Hui Yang; Jing Li; Ruihua Tang; Yaxiong Liu; Yan Shao; Qingsheng Huang; Junling Shi
Journal:  Med Sci Monit       Date:  2015-02-26

9.  Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer.

Authors:  Weiying Li; Wentao Yue; Hui Wang; Baitang Lai; Xuehui Yang; Chunyan Zhang; Yue Wang; Meng Gu
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

10.  Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.

Authors:  Dawei Tian; Yan Sun; Yang Yang; Mingde Lei; Na Ding; Ruifa Han
Journal:  Onco Targets Ther       Date:  2013-04-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.